What is the diagnosis and treatment for abnormal movements after discontinuing Ativan (lorazepam), benztropine, and Buspar (buspirone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for Abnormal Movements after Stopping Medications

The patient presents with abnormal movements after discontinuing Ativan (lorazepam), benztropine, and Buspar (buspirone). The differential diagnosis can be categorized as follows:

  • Single Most Likely Diagnosis

    • Withdrawal-induced movement disorder: This is the most likely diagnosis, given the recent cessation of medications, particularly Ativan, which is a benzodiazepine known to cause withdrawal symptoms, including movement disorders. Benztropine, an anticholinergic, can also contribute to movement issues upon withdrawal.
  • Other Likely Diagnoses

    • Tardive dyskinesia: Although less likely since benztropine was being used (which can sometimes prevent or treat tardive dyskinesia), the recent stoppage of this medication could unmask underlying tardive dyskinesia, especially if the patient was on other medications that could cause this condition.
    • Akathisia: This condition, characterized by subjective and objective restlessness, could be a result of the withdrawal from the medications, particularly from the cessation of buspirone, which can sometimes cause or exacerbate akathisia.
  • Do Not Miss Diagnoses

    • Serotonin syndrome: Although the patient stopped Buspar, which is not typically associated with serotonin syndrome, any recent changes in medication, including the stoppage of certain drugs, can sometimes lead to unpredictable interactions, especially if other serotonergic agents were recently introduced or increased in dosage.
    • Neuroleptic malignant syndrome (NMS): This rare but life-threatening condition can occur due to the withdrawal of medications that affect dopamine, especially if there was a recent use of neuroleptics or other dopamine-blocking agents not mentioned.
  • Rare Diagnoses

    • Dopamine agonist withdrawal syndrome: If the patient was on any dopamine agonists (not mentioned), stopping these could lead to a withdrawal syndrome that includes movement disorders.
    • Wilson's disease: A rare genetic disorder that leads to copper accumulation in the body, causing neurological symptoms, including movement disorders. This would be unrelated to the medication stoppage but could be considered if other symptoms or signs suggest this diagnosis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.